CVE-2023-4667
Published: 28 November 2023
Summary
CVE-2023-4667 is a high-severity Cross-site Scripting (CWE-79) vulnerability in Idemia Morphowave Sp Firmware. Its CVSS base score is 8.1 (High).
Operationally, ranked at the 27.7th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2023-54519
Vulnerability details
The web interface of the PAC Device allows the device administrator user profile to store malicious scripts in some fields. The stored malicious script is then executed when the GUI is opened by any users of the webserver administration interface.…
more
The root cause of the vulnerability is inadequate input validation and output encoding in the web administration interface component of the firmware. This could lead to unauthorized access and data leakage
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.